24/7
Buzz
Startups
VC
@work
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
DataTech
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Quris
Tags search
HOME
24/7
buzz
STARTUPS
VC
Tech@work
Innovation
OPINIONS
EVENTS
ABOUT
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:40
Former Shin Bet director's cyber startup Opora is shutting down
18:30
Comeet and Spark Hire to merge in $50 million deal
17:52
Funding a better future: How do you invest in startups that are battling the climate crisis?
16:48
Full list of Israeli high-tech layoffs in 2022-23
More stories
Buzz
Most popular
Daily
Weekly
1
Why did SentinelOne shares plummet by 35% in a single day?
2
91 Ventures launches $15 million early-stage VC fund
3
Cyber unicorn Snyk acquiring Israeli startup Enso Security for over $50 million
4
Former Shin Bet director's cyber startup Opora is shutting down
5
The 50 most promising Israeli startups - 2023
More news
Quris
5 stories about Quris
SoftBank leads $9 million investment in AI pharma startup Quris
20.12.22
|
Meir Orbach
The Israeli startup expanded its Seed funding to $37 million and plans to use the additional investment to advance its Bio-AI clinical-prediction platform that simulates clinical trials
CTech’s Book Review: Breaking down the barriers to set you free
13.07.22
|
Isaac Bentwich
Isaac Bentwich, Founder and CEO of Quris Technologies, shares insights after reading “Untethered Soul” by Michael A. Singer
Pharma giant Merck inks deal with Israel’s Quris for clinical safety prediction
09.02.22
|
Meir Orbach
The Israeli company which develops predictive technology based on artificial intelligence has signed an agreement worth tens of millions of dollars to test drugs by the pharma giant
Quris closes record $28 million Seed funding for AI drug development platform
11.01.22
|
Meir Orbach
The Israeli startup uses AI-powered miniaturized “patients-on-a-chip” to avoid the risks and costs of failed clinical trials and eliminate the reliance on ineffective animal testing
Quris raises $9 million in Seed for its clinician prediction AI platform
21.10.21
|
James Spiro
The announcement coincides with the launch of its platform via a partnership with the NYSCF Research Institute.
Please ensure Javascript is enabled for purposes of
website accessibility